Literature DB >> 7538098

Hepatitis A, B and C seroprevalence in Pakistan.

M Agboatwalla1, S Isomura, K Miyake, T Yamashita, T Morishita, D S Akram.   

Abstract

A cross sectional study was conducted to determine the seroprevalence of Hepatitis A, B, and C virus in healthy Pakistani children. HAV IgG antibody was assayed in 258 subjects and it was found that 94% children by 5 years of age had HAV IgG-antibody. The overall seroprevalence of HAV IgG antibody was 55.8% and IgM 5.3%. HBVsAb levels assayed in 236 healthy children showed a seroprevalence of 2.97%. Similarly, HCV antibody seroprevalence was found to be a low 0.44% in healthy children. HAV is a major cause of Hepatitis, as compared to HBV and HCV which are of low endemicity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7538098     DOI: 10.1007/bf02751716

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  20 in total

1.  Prevalence of hepatitis C virus antibodies and hepatitis C virus-RNA in an urban population.

Authors:  M Rapicetta; A F Attili; A Mele; A De Santis; P Chionne; K Cristiano; E Spada; E Giuliani; L Carli; F Goffredo
Journal:  J Med Virol       Date:  1992-06       Impact factor: 2.327

Review 2.  Hepatitis A virus infection: new insights from seroepidemiologic studies.

Authors:  J L Dienstag; W Szmuness; C E Stevens; R H Purcell
Journal:  J Infect Dis       Date:  1978-03       Impact factor: 5.226

Review 3.  Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis.

Authors:  Q L Choo; A J Weiner; L R Overby; G Kuo; M Houghton; D W Bradley
Journal:  Br Med Bull       Date:  1990-04       Impact factor: 4.291

4.  Liver disorders in children.

Authors:  A Mehnaz; A G Billo; S J Zuberi
Journal:  J Pak Med Assoc       Date:  1990-03       Impact factor: 0.781

5.  Prevalence of virus A exposure and viral hepatitis A in India.

Authors:  B M Gandi; Y K Joshi; B N Tandon
Journal:  Lancet       Date:  1981-08-15       Impact factor: 79.321

6.  The changing epidemiologic pattern of hepatitis A infection in urban Greece.

Authors:  J Kremastinou; V Kalapothaki; D Trichopoulos
Journal:  Am J Epidemiol       Date:  1984-11       Impact factor: 4.897

7.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

8.  Etiological types and clinical and epidemiological features of acute viral hepatitis in Xi'an in China.

Authors:  D Z Xu; W Y Zhou; H K Zou; Y J Chen
Journal:  J Med Virol       Date:  1987-03       Impact factor: 2.327

9.  Hepatitis B virus infection in pregnant mothers and its transmission to infants.

Authors:  S Akhter; M Q Talukder; N Bhuiyan; T A Chowdhury; M N Islam; S Begum
Journal:  Indian J Pediatr       Date:  1992 Jul-Aug       Impact factor: 1.967

10.  The epidemiology of hepatitis C virus antibody in Yemen.

Authors:  D A Scott; N T Constantine; J Callahan; J P Burans; J G Olson; M al-Fadeel; H al-Ozieb; H Arunkumer; K C Hyams
Journal:  Am J Trop Med Hyg       Date:  1992-01       Impact factor: 2.345

View more
  13 in total

1.  Epidemiological factors affecting hepatitis a seroprevalence in childhood in a developing country.

Authors:  Sevin Altınkaynak; Mukadder Ayşe Selimoğlu; Vildan Ertekin; Buket Kılıçaslan
Journal:  Eurasian J Med       Date:  2008-04

Review 2.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

3.  Detection of antibodies to hepatitis C virus in dried blood spot samples from mothers and their offspring in Lahore, Pakistan.

Authors:  S P Parker; H I Khan; W D Cubitt
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

Review 4.  Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors.

Authors:  Yasir Waheed; Talha Shafi; Sher Zaman Safi; Ishtiaq Qadri
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

Review 5.  Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors.

Authors:  Syed Asad Ali; Rafe M J Donahue; Huma Qureshi; Sten H Vermund
Journal:  Int J Infect Dis       Date:  2008-10-02       Impact factor: 3.623

Review 6.  Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data.

Authors:  Muhammad Umer; Mazhar Iqbal
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

7.  Hepatitis C in Pakistan: a review of available data.

Authors:  Muhammad Umar; Hamama Tul Bushra; Masood Ahmad; Available Data; Masood Ahmad; Muhammad Khurram; Saima Usman; Mohammad Arif; Tashfeen Adam; Zahid Minhas; Adnan Arif; Abdul Naeem; Khushnud Ejaz; Zameer Butt; Muhammad Bilal
Journal:  Hepat Mon       Date:  2010-09-01       Impact factor: 0.660

8.  Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan.

Authors:  Wasim Jafri; Nadim Jafri; Javed Yakoob; Muhammad Islam; Syed Farhan Ali Tirmizi; Tazeen Jafar; Saeed Akhtar; Saeed Hamid; Hasnain Ali Shah; Sheikh Qamaruddin Nizami
Journal:  BMC Infect Dis       Date:  2006-06-23       Impact factor: 3.090

9.  A cross-sectional assessment of knowledge, attitude and practice among Hepatitis-B patients in Quetta, Pakistan.

Authors:  Noman ul Haq; Mohamed Azmi Hassali; Asrul Akmal Shafie; Fahad Saleem; Maryam Farooqui; Abdul Haseeb; Hisham Aljadhey
Journal:  BMC Public Health       Date:  2013-05-06       Impact factor: 3.295

10.  A cross sectional assessment of knowledge, attitude and practice towards Hepatitis B among healthy population of Quetta, Pakistan.

Authors:  Noman ul Haq; Mohamed Azmi Hassali; Asrul A Shafie; Fahad Saleem; Maryam Farooqui; Hisham Aljadhey
Journal:  BMC Public Health       Date:  2012-08-23       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.